Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. (Q34624122)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. |
scientific article |
Statements
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer (English)
Andrés Cervantes
Alberto F Sobrero
Michel Ducreux
Yevhen Hotko
Emily Chan
Florian Lordick
Cornelis J A Punt
Andrew H Strickland
Gregory Wilson
Tudor-Eliade Ciuleanu
Laslo Roman
Valentina Tzekova
Simon Collins
Kelly S Oliner
Alan Rong
Jennifer Gansert
Eric Van Cutsem